Global Anticancer Drugs Market Forecast 2022

 

Anticancer drugs are used to treat malignancies, or cancerous growths. Drug therapy may be used alone, or in combination with other treatments such as surgery or radiation therapy.
Anticancer drugs are used to control the growth of cancerous cells. Cancer is commonly defined as the uncontrolled growth of cells, with loss of differentiation and commonly, with metastasis, spread of the cancer to other tissues and organs. Cancers are malignant growths. In contrast, benign growths remain encapsulated and grow within a well-defined area.

Although benign tumors may be fatal if untreated, due to pressure on essential organs, as in the case of a benign brain tumor, surgery or radiation are the preferred methods of treating growths which have a defined location. Drug therapy is used when the tumor has spread, or may spread, to all areas of the body.


At present, most common solid tumors, such as lung cancer, liver cancer, colon cancer and pancreatic cancer, still lack effective drugs, and many anticancer drugs have drug resistance in the course of clinical application. Therefore, the research of new anticancer drugs is imperative. In recent years, with the rapid development of science and technology and advances in molecular oncology and molecular biology technology, new anticancer drugs have been discovered.


The "Global Anticancer Drugs Market Research Report 2017" released by GlobalInfoResearch shows that the revenue of anticancer drugs is about 121.25 billion USD in 2016 all around the world. And the anticancer drugs market will reach 173.23 billion USD by 2022, with a CAGR 7.4% (2016-2022).

 

GlobalInfoResearch ALL Rights Reserved